Semaglutide shows promise in reducing tobacco use disorder-related health encounters in patients with type 2 diabetes, but further clinical trials are needed to confirm its efficacy.
Semaglutide may reduce smoking risks for diabetes patients
- Post author:
- Post published:July 29, 2024
- Post category:uncategorized